CLINICAL HETEROGENEITY OF INSULIN-DEPENDENT DIABETES-MELLITUS IN KOREA

被引:5
作者
LEE, KU
KIM, SW
PARK, JY
KO, KS
RHEE, BD
MIN, HK
机构
[1] UNIV ULSAN,COLL MED,DEPT MED,SEOUL,SOUTH KOREA
[2] INJE UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[3] SEOUL NATL UNIV HOSP,DEPT INTERNAL MED,SEOUL 110744,SOUTH KOREA
[4] CHEIL GEN HOSP,SEOUL,SOUTH KOREA
关键词
INSULIN-DEPENDENT DIABETES MELLITUS; CLASSIFICATION; HETEROGENEITY; C-PEPTIDE; ONSET AGE;
D O I
10.1016/0168-8227(95)01027-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was undertaken to find out how many current Korean patients with insulin dependent diabetes mellitus (IDDM) had a previous history of non-insulin requiring phase, Fasting serum C-peptide levels were measured in the 2300 diabetic patients during the visit to the Asan Medical Center, Seoul, Korea. Fifty-nine patients showed fasting serum C-peptide levels below 0.13 nmol/l. These 59 patients were classified further into two groups according to their history of insulin requirement: group A who required insulin within 1 year after diagnosis or presented initially as diabetic ketoacidosis and group B who had non-insulin requiring phase at least for 1 year (median: 5 years; range: 1-23 years). Twenty-six patients (44%) were classified into group A and 27 patients (46%) into group B. Median age of onset was 26 years (range: 10-50 years) and 45 years (range: 23-73 years) in groups A and B, respectively (P < 0.001). While the two groups had similar values in the current and maximum body mass indices, sex ratio and the prevalence of islet cell antibodies, 58% of the group A and 7% of the group B patients had histories of diabetic ketoacidosis. These results suggest a clinical heterogeneity in patients with IDDM in Korea.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 12 条
[1]   TYPES OF DIABETES ACCORDING TO NATIONAL DIABETES DATA GROUP CLASSIFICATION - LIMITED APPLICABILITY AND NEED TO REVISIT [J].
ABOURIZK, NN ;
DUNN, JC .
DIABETES CARE, 1990, 13 (11) :1120-1123
[2]   OBESITY, ALBUMINURIA AND HYPERTENSION AMONG HONG-KONG CHINESE WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) [J].
CHAN, JCN ;
CHEUNG, CK ;
SWAMINATHAN, R ;
NICHOLLS, MG ;
COCKRAM, CS .
POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (809) :204-210
[3]   FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO CLINICAL TYPE OF DIABETES [J].
GJESSING, HJ ;
MATZEN, LE ;
FABER, OK ;
FROLAND, A .
DIABETOLOGIA, 1989, 32 (05) :305-311
[4]   ISLET CELL ANTIBODIES IDENTIFY LATENT TYPE-I DIABETES IN PATIENTS AGED 35-75 YEARS AT DIAGNOSIS [J].
GROOP, LC ;
BOTTAZZO, GF ;
DONIACH, D .
DIABETES, 1986, 35 (02) :237-241
[5]   A REVIEW OF THE RECENT EPIDEMIOLOGIC DATA ON THE WORLDWIDE INCIDENCE OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
KARVONEN, M ;
TUOMILEHTO, J ;
LIBMAN, I ;
LAPORTE, R .
DIABETOLOGIA, 1993, 36 (10) :883-892
[6]  
KIM YT, 1990, J KOREAN DIABETES AS, V14, P185
[7]   IMMUNOGENETIC AND CLINICAL CHARACTERIZATION OF SLOWLY PROGRESSIVE IDDM [J].
KOBAYASHI, T ;
TAMEMOTO, K ;
NAKANISHI, K ;
KATO, N ;
OKUBO, M ;
KAJIO, H ;
SUGIMOTO, T ;
MURASE, T ;
KOSAKA, K .
DIABETES CARE, 1993, 16 (05) :780-788
[8]   MITOCHONDRIAL GENE MUTATION IN ISLET-CELL-ANTIBODY-POSITIVE PATIENTS WHO WERE INITIALLY NON-INSULIN-DEPENDENT DIABETICS [J].
OKA, Y ;
KATAGIRI, H ;
YAZAKI, Y ;
MURASE, T ;
KOBAYASHI, T .
LANCET, 1993, 342 (8870) :527-528
[9]  
PARK KS, 1994, 15TH INT DIAB FED C
[10]  
ROSETTI L, 1990, DIABETES CARE, V13, P610